Found 10 hits for monomerid = 50136768 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Somatostatin receptor type 1
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human somatostatin receptor type 1 using [125I]-[Leu8,DTrp22,Tyr25]SRIF-28 as radioligand. |
J Med Chem 46: 5597-605 (2003)
Article DOI: 10.1021/jm030245x
BindingDB Entry DOI: 10.7270/Q2MK6C9X |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human somatostatin receptor type 5 using [125I]-[Leu8,DTrp22,Tyr25]SRIF-28 as radioligand. |
J Med Chem 46: 5597-605 (2003)
Article DOI: 10.1021/jm030245x
BindingDB Entry DOI: 10.7270/Q2MK6C9X |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 4
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human somatostatin receptor type 4 using [125I]-[Leu8,DTrp22,Tyr25]SRIF-28 as radioligand. |
J Med Chem 46: 5597-605 (2003)
Article DOI: 10.1021/jm030245x
BindingDB Entry DOI: 10.7270/Q2MK6C9X |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 3
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human somatostatin receptor type 3 using [125I]-[Leu8,DTrp22,Tyr25]SRIF-28 as radioligand. |
J Med Chem 46: 5597-605 (2003)
Article DOI: 10.1021/jm030245x
BindingDB Entry DOI: 10.7270/Q2MK6C9X |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human Somatostatin receptor type 2 using 125I-[Leu,DTrp,Tyr]SRIF-28 as radioligand |
J Med Chem 46: 5579-86 (2003)
Article DOI: 10.1021/jm030243c
BindingDB Entry DOI: 10.7270/Q2KP82W9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 4
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human Somatostatin receptor type 4 using 125I-[Leu,DTrp,Tyr]SRIF-28 as radioligand |
J Med Chem 46: 5579-86 (2003)
Article DOI: 10.1021/jm030243c
BindingDB Entry DOI: 10.7270/Q2KP82W9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 3
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human Somatostatin receptor type 3 using 125I-[Leu,DTrp,Tyr]SRIF-28 as radioligand |
J Med Chem 46: 5579-86 (2003)
Article DOI: 10.1021/jm030243c
BindingDB Entry DOI: 10.7270/Q2KP82W9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 1
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human Somatostatin receptor type 1 using 125I-[Leu,DTrp,Tyr]SRIF-28 as radioligand |
J Med Chem 46: 5579-86 (2003)
Article DOI: 10.1021/jm030243c
BindingDB Entry DOI: 10.7270/Q2KP82W9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human Somatostatin receptor type 5 using 125I-[Leu,DTrp,Tyr]SRIF-28 as radioligand |
J Med Chem 46: 5579-86 (2003)
Article DOI: 10.1021/jm030243c
BindingDB Entry DOI: 10.7270/Q2KP82W9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM50136768
(CHEMBL442315 | Peptide analogue | Somatostatin ana...)Show SMILES CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C(N)C(C)=C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C139H209N41O38S3/c1-70(2)108(146)132(212)157-73(5)113(193)167-94(61-103(143)185)125(205)174-97(66-181)127(207)173-96(63-105(145)187)136(216)180-55-30-44-101(180)130(210)156-72(4)112(192)160-89(48-56-219-9)115(195)158-74(6)135(215)179-54-29-45-102(179)131(211)166-87(43-28-53-152-139(149)150)117(197)165-88(46-47-107(189)190)119(199)162-86(42-27-52-151-138(147)148)116(196)161-83(39-21-24-49-140)114(194)155-71(3)111(191)154-65-106(188)159-99-68-220-221-69-100(137(217)218)176-128(208)98(67-182)175-134(214)110(76(8)184)178-126(206)92(59-79-35-17-12-18-36-79)172-133(213)109(75(7)183)177-120(200)85(41-23-26-51-142)163-123(203)93(60-80-64-153-82-38-20-19-37-81(80)82)170-122(202)91(58-78-33-15-11-16-34-78)168-121(201)90(57-77-31-13-10-14-32-77)169-124(204)95(62-104(144)186)171-118(198)84(164-129(99)209)40-22-25-50-141/h10-20,31-38,64,71-76,83-102,108-110,153,181-184H,1,21-30,39-63,65-69,140-142,146H2,2-9H3,(H2,143,185)(H2,144,186)(H2,145,187)(H,154,191)(H,155,194)(H,156,210)(H,157,212)(H,158,195)(H,159,188)(H,160,192)(H,161,196)(H,162,199)(H,163,203)(H,164,209)(H,165,197)(H,166,211)(H,167,193)(H,168,201)(H,169,204)(H,170,202)(H,171,198)(H,172,213)(H,173,207)(H,174,205)(H,175,214)(H,176,208)(H,177,200)(H,178,206)(H,189,190)(H,217,218)(H4,147,148,151)(H4,149,150,152)/t71-,72-,73-,74-,75+,76+,83-,84+,85-,86-,87-,88-,89-,90+,91-,92+,93+,94-,95-,96-,97-,98+,99+,100+,101-,102-,108?,109+,110-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Binding affinity towards human somatostatin receptor type 2 using [125I]-[Leu8,DTrp22,Tyr25]SRIF-28 as radioligand. |
J Med Chem 46: 5597-605 (2003)
Article DOI: 10.1021/jm030245x
BindingDB Entry DOI: 10.7270/Q2MK6C9X |
More data for this
Ligand-Target Pair | |
Search and Browse
